Georgetown University Med Ctr — Washington D.C., District of Columbia

Georgetown University Med Ctr is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Georgetown University Med Ctr has participated in 3 clinical trials.

Therapeutic areas: Myeloid Leukemia, Chronic, Chronic-Phase, Melanoma, Esophageal Cancer.

Sponsors: Bristol-Myers Squibb, Ono Pharmaceutical Co. Ltd.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown University Med Ctr?

Georgetown University Med Ctr has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown University Med Ctr conducted?

Georgetown University Med Ctr has 3 clinical trials on record. Their work covers Myeloid Leukemia, Chronic, Chronic-Phase, Melanoma, Esophageal Cancer.

Is Georgetown University Med Ctr accredited by Crixeo Health?

Georgetown University Med Ctr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown University Med Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.